摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-FORMYL-4-HYDROXY-5-METHOXYPHENYL)ACETIC ACID | 765302-59-8

中文名称
——
中文别名
——
英文名称
2-(3-FORMYL-4-HYDROXY-5-METHOXYPHENYL)ACETIC ACID
英文别名
——
2-(3-FORMYL-4-HYDROXY-5-METHOXYPHENYL)ACETIC ACID化学式
CAS
765302-59-8
化学式
C10H10O5
mdl
——
分子量
210.186
InChiKey
ICXMVLCFPVIQCS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    392.8±42.0 °C(Predicted)
  • 密度:
    1.392±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    83.8
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(3-FORMYL-4-HYDROXY-5-METHOXYPHENYL)ACETIC ACID硫酸 作用下, 反应 6.0h, 以88%的产率得到Ethyl 2-(3-formyl-4-hydroxy-5-methoxyphenyl)acetate
    参考文献:
    名称:
    Non-nucleoside reverse transcriptase inhibitors
    摘要:
    本发明提供了用于治疗或预防HIV感染,治疗艾滋病或ARC的化合物,包括根据以下公式I给予化合物,其中Ar,R1-R5,R7a,R7b,R7c,R8-R10,X1,X2m,n,o和p如本文所定义。
    公开号:
    US20050239881A1
  • 作为产物:
    描述:
    高香草酸乌洛托品 作用下, 反应 4.0h, 以61%的产率得到2-(3-FORMYL-4-HYDROXY-5-METHOXYPHENYL)ACETIC ACID
    参考文献:
    名称:
    Non-nucleoside reverse transcriptase inhibitors
    摘要:
    本发明提供了用于治疗或预防HIV感染,治疗艾滋病或ARC的化合物,包括根据以下公式I给予化合物,其中Ar,R1-R5,R7a,R7b,R7c,R8-R10,X1,X2m,n,o和p如本文所定义。
    公开号:
    US20050239881A1
点击查看最新优质反应信息

文献信息

  • Bi-functional complexes and methods for making and using such complexes
    申请人:Gouliaev Alex Haahr
    公开号:US11225655B2
    公开(公告)日:2022-01-18
    The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.
    本发明涉及一种合成双功能复合物的方法,该复合物包括分子部分和识别分子部分的识别寡核苷酸部分。根据本发明的合成方法的一部分优选在一种或多种有机溶剂中进行,此时包含可选保护标签或寡核苷酸标识符的新生双功能复合物与固体支持物相连接,合成方法的另一部分优选在适合于将寡核苷酸标签酶加到溶液中的新生双功能复合物的条件下进行。
  • BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
    申请人:Nuevolution A/S
    公开号:EP2558577A1
    公开(公告)日:2013-02-20
  • BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
    申请人:Gouliaev Alex Haahr
    公开号:US20130281324A1
    公开(公告)日:2013-10-24
    The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.
  • [EN] BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES<br/>[FR] COMPLEXES BIFONCTIONNELS ET PROCÉDÉS DE FABRICATION ET D'UTILISATION DE TELS COMPLEXES
    申请人:NUEVOLUTION AS
    公开号:WO2011127933A1
    公开(公告)日:2011-10-20
    The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.
查看更多